New Submission Guidance
General guidance on submitting a new study can be found in the presentation, "10 Steps to IRB Approval."
Initial Submission Guidance and Documents
- Emory IRB Submission Type Guidance Chart
- OHRP Human Subject Decision Charts
- Humanitarian Use Device (HUD) Checklist
Clinical Study Tools, Templates and Checklists
Please see the "Clinical Study Initiation" section at left.
Departmental Review Help
- Please look for the correct Departmental Approval department using this list. See FAQ (under Departmental Approval section) for more details.
Lay Summary Guidelines
- Retrospective Chart Review
- Secondary Data/Specimen Analysis
- Repository/Registry/Database NEW
- HUD for Treatment Use
Advertisement, Recruitment, Compensation
- Advertising and Recruitment: Guidance & Information
- Can raffles be used as compensation? Only if you offer to everyone. See here: https://www.ogc.emory.edu/downloads/advisories/RafflesAndOtherContestGiveaways.pdf
Checklists for Department of Defense and ICH-GCP
Costs and In Case of Injury Policies
These policies are the basis for the required language you find in our consent form templates.
- External Sponsors: Emory Policy on Costs of Participation
- Injuries Related to Research: Emory Policy on Costs
Additional Study Documents and Guidance
- LITS approved apps for research-version 6/7/2017
- NIH Targeted/Planned Enrollment Table
- Questionnaires, Rating Scales, Interviews
- Site Permission Letter
- Email encription information (from LITS): email encryption is required if emailing sensitive information to people outside Emory or consents (even if empty) to study participants.
Data and Safety Monitoring Boards and Plans Guidance
- Mobile Medical apps worksheet
- Emory IRB Medical Device Guidance- New
- FDA-CDER Chronicles: Drug, Not a drug, or More
- Dietary Supplements FAQ
- Dietary Supplements and/or Medical Foods Worksheet
- Expanded Access Use - Devices
- Expanded Access Use - Drugs
- Guidance for Emory Sponsor-Investigators
- HUD Patient Information Sheet
- Investigational Drugs and Devices
- Investigator Justification for IDE Exemption
- Investigator Justification for IND Exemption
Review by applicable compliance/oversight offices is needed before IRB can issue final approval, or (in the case of Office of Quality) before IRB can issue stamped consent forms. eIRB has integrated approval buttons for each of these offices, but you must submit applications separately to each.
- Biosafety Review Guidelines. Special Recombinant DNA review is also needed for studies falling under the NIH policy.
- Conflict of Interest Guidance for Emory University. When you disclose COI in our eIRB smartform, the IRB must receive a determination from the COI office prior to final IRB approval. The IRB also reviews all COI management plans, and may rarely add additional requirements to the plans.
- CTRC: Reviews all cancer-related resarch involving Emory (not solely studies taking place at Winship Cancer Institute; includes chart reviews, public health studies, surveys, etc). CTRC approval usually must be in place before the IRB begins our review; eIRB sets this requirement automatically when "Cancer-Related Research" is checked off under "Biomedical Research" section (for chart reviews or other studies that don't trigger that page of the eIRB smartform, you can check it off via the jump-to mention at the top of each page; or, the IRB staff will catch it once the study comes to us and route it at that point). Please see https://winshipcancer.emory.edu/research/clinical-trials-office/clinical-translational-review-committee.html for information and application form (submit to CTRC directly, outside of eIRB; may be done prior to eIRB submission but you must have created a new study, to generate an eIRB number).
- Office of Quality Checklist: The Office of Quality oversees completion of multiple sign-off's required before study initiation, e.g. nursing, pharmacy, laboratory, radiology. Some parts of the checklists for sign-off are now built into eIRB; the radiology and laboratory ones can be found here: http://irb.emory.edu/forms/clinical.html. Office of Quality final sign-off must be in place before the IRB releases stamped consent forms, but does not hold up IRB approval.
- Radiation Safety: Complete Radiation Summary Form, and the Human Studies Application for Radiation Use, and print, sign, and submit by fax (404-727-9778) or scanned email to Ike Hall (firstname.lastname@example.org). Also upload Radiation Summary Form into eIRB submission, under "Miscellaneous Documents." The Radiation Summary Form determines what consent form language to use for describing the risks of the radiation in your study. Call the office with questions: http://www.ehso.emory.edu/about/contact.html
- RDRC: A radiation subcommittee that reviews basic research using radioactive drugs in humans without an IND (must be 30 or fewer subjects). Contact Ike Hall (email@example.com) for the application.
- HIPAA changes FAQ plus decision chart version 2/23/2017
- Identifiers: Examples
- Online Survey Providers and HIPAA Compliance
Vulnerable Populations Worksheets
- Guidance Sheet for Cognitively Impaired
- Minor/Children Subjects Worksheets
- Pregnant Women, Fetuses, and Neonates
- Prisoner Subjects
- Research Involving Individuals with Questionable Capacity to Consent (NIH)
- Family members as interpreters
Children's Healthcare of Atlanta
- Children's Healthcare of Atlanta is an entity distinct from Emory. When doing research that involves CHOA, please see the "Collaborative Research" section at left (CHOA information at bottom of page), and always submit this form to the CHOA IRB even when Emory is the IRB of record: CHOA IAA Acknowledgement Form
- IRB Application for Medical Imaging Dose Estimate
Grady and St. Joseph's Hospital Studies
- Forms and Contact Information from Grady's Office of Research Administration
- Emory-St. Joseph's Hospital Clinical Research Procedures